The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Cancer and therapeutic vaccines at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

5 organizations at World Vaccine Congress 2027 present work in cancer & therapeutic vaccines: 3 vaccine and drug developers and 2 academic bodies. Between them they bring 5 presentations to the program. Most represented: Anixa Biosciences (2 on the program), HDT Bio (2 on the program), City of Hope (1 on the program). As of Oct 8, 2026.

All 222 organizations at World Vaccine Congress 2027 →

Showing 1–5 of 5 organizations

Organization	World Vaccine Congress 2027 Attendance
Anixa Biosciences San Jose, CA
anixa.com Biotech Biotech developing a preventive breast cancer vaccine with Cleveland Clinic and a CAR-T therapy for ovarian cancer.	Talk Wed Mar 10 12:25 Targeting retired tissue-specific proteins to enable primary prevention of triple-negative breast cancer Cancer & Immunotherapy Track
HDT Bio Seattle, WA
hdt.bio Biotech Develops RNA vaccines and immunotherapies on a nanoparticle delivery platform for infectious diseases and cancer.	Talk Wed Mar 10 15:40 LION Nano-formulation Technology for the Development of Personalized Cancer Vaccines Cancer & Immunotherapy Track
City of Hope Duarte, CA
cityofhope.org Academic Cancer research and treatment center designated a comprehensive cancer center by the US National Cancer Institute.	Talk Wed Mar 10 10:10 Joint Presentation: Neoantigen-Based Cancer Vaccines: From Prediction to Clinical Translation Cancer & Immunotherapy Track · with myNEO Therapeutics
myNEO Therapeutics Ghent, Belgium
myneotx.com Biotech Belgian biotech using machine learning on tumour data to find targets for personalized cancer vaccines and immunotherapies.	Talk Wed Mar 10 10:10 Joint Presentation: Neoantigen-Based Cancer Vaccines: From Prediction to Clinical Translation Cancer & Immunotherapy Track · with City of Hope
The Wistar Institute Philadelphia, PA
wistar.org Academic Independent biomedical research institute studying cancer, immunology and infectious disease, with a long history of vaccine development.	Panel Wed Mar 10 09:10 Panel topic: Cold Tumors & Shared vs. Personalised Targets How cancer vaccines can work in tumors the immune system ignores, comparing shared and personalized targets, delivery platforms and manufacturing costs.